EGFR modulation using EGF or an EGFR inhibitor markedly influenced viability and response to I3C in MDA-MB-468 cells in 3D conditions. EGFR expression was modulated by 3D conditions. Therefore, I3C-induced EGFR reduction in these cells is likely to be responsible for I3C-induced apoptosis.
Introduction
Breast cancer has the highest incidence in women in the Western world compared to other forms of cancer. In England and Wales, the number of breast cancer cases between 1988-1990 exceeded the number of cases of lung and colon cancer taken together. 1 Current estimates indicate that one in eight women will be diagnosed with breast cancer in her lifetime. Epidemiological studies and analysis of diet suggest that consumption of some foods, e.g. those containing genistein, coincides with the reduced risk of breast cancer. 2, 3 Indole-3-carbinol (I3C), derived from vegetables of the Cruciferae family, such as broccoli, brussel sprouts and cabbage, has been shown to inhibit development of tumors in a variety of tissues in animal models (thoroughly reviewed in 4 ). It reduces or delays development of mammary tumors induced by carcinogens and viruses, as well as growth of spontaneous mammary tumors in animal models. Therefore, it is regarded as a promising chemopreventive agent. Two clinical phase II trials indicated that I3C causes significant regression of cervical intraepithelial neoplasia and recurrent respiratory papillomatosis in patients. 5, 6 The chemopreventive efficacy of I3C can be partially attributed to its effect on estradiol metabolism, since it increases 2-hydroxylation and decreases proliferative activity of endogenous estrogens in volunteers and patients, as well as in animal models. 4, 5, 7, 8 However, both estrogen receptor (ER)-negative MDA-MB-231 and MDA-MB-468 cells and ER-positive MCF7 breast cancer cells are affected by I3C. I3C has been reported to inhibit growth of MDA-MB-231 cells and induce apoptosis in MDA-MB-468 and MCF7 cells. [9] [10] [11] [12] [13] Therefore, the mechanisms of I3C-induced growth inhibition or apoptosis are not related to ER status and remain obscure.
Data on the mechanism of I3C-induced apoptosis are contradictory. I3C-induced apoptosis was related to increased death receptors, DR4 and DR5, in prostate cancer LNCaP cells, which points to an extrinsic apoptotic pathway.
as post-apoptotic events. 13 Furthermore, several studies showed that I3C upregulates expression of pro-apoptotic proteins, e.g. DR4, DR5, caspase-1 and Bax, at transcriptional and protein levels. [14] [15] [16] 19 Therefore, we investigated which initiator caspase was involved in the apoptotic pathway in breast cancer cells in more detail. We also examined epidermal growth factor receptor (EGFR), which is required for maintaining viability of EGFR-dependent solid tumours, 20 as a primary I3C target. EGFR signaling plays an important role in cancer development and progression. 21 Cells in tissues are involved in three-dimensional interactions, and it is well known that their physiology and fate is influenced by a 3D environment. Modulation of cell adhesion in laminin-based 3D culture dramatically influences morphology and function of breast cancer cells. 22, 23 Laminin-based and spheroid 3D cultures protect some breast cells from apoptosis or increase resistance to cytotoxic agents compared to monolayer culture. [24] [25] [26] The aim of this study was to investigate whether 3D culture altered the susceptibility of breast cancer cells to I3C. Collagen-based 3D culture is more relevant for our investigation, because breast cancer is associated with basement membrane fragmentation, increased collagen synthesis and accumulation. 23, 27 Aggressive breast cancer induces a strong fibroproliferative response with synthesis of type I collagen. 28 Metastatic spreading of breast cancer cells in vivo occurs along collagen filaments. 29 Moreover, drug resistance tests using collagen gel culture have proved to be accurate and highly predictive. 30, 31 All cell lines used in this study express α2β1 integrin, 32 responsible for adhesion to collagen I. The other 3D model we investigated was spheroid culture, because in some cases cells in spheroids are more resistant to cytotoxic agents than in monolayer culture. 25, 26 For these reasons, we compared the effect of I3C on breast cells grown in monolayers and in two 3D models.
We investigated I3C-induced cell death in human breast cancer cells in comparison to the transformed breast cell line HBL100 and normal fibroblasts. A panel of cancer cell lines (MCF7, MDA-MB-468 and MDA-MB-231) was chosen to represent cells with a wide range of tumorigenicity. They produce tumors in nude mice with efficiencies of 22, 90 and 100%, and are known as non-metastatic, poorly metastatic and aggressively metastatic, respectively. 33, 34 The breast cell line HBL100, derived from normal human breast epithelium and containing integrated defective SV40 virus, was also included in the study. This transformed cell line is able to form colonies in soft agar and produce adenocarcinomas in nude mice. 35 All cells were cultured as described previously. 32 Normal human fibroblasts GM05399 were obtained from Coriell Cell Repositories (Camden, NJ, USA) and used in passages 12-16. For culture in collagen gels, collagen I (Invitrogen) was diluted in DMEM to the concentration of 1 mg/ml (on ice), the pH adjusted to within physiological range, mixed with cells and dispensed in Packard Viewplates-96 (2500 cells/100 µl per well). After 1 h incubation at 37
• C to set collagen gels, an equal volume of the medium containing 20% FBS was added. In some experiments an equal amount (1 mg/ml) of growth factor-reduced matrigel (BD Biosciences) was added to collagen I before mixing with cells. Spheroids were generated by seeding 2.5×10 4 cells/ml on to 0.8% agarose-coated 24-well tissue culture plates and overnight incubation. The DMSO amounts were equal in all wells in all experiments and did not exceed 0.1%.
Cell viability and apoptosis-related studies
The viability of cells in response to I3C was determined by measuring ATP levels, since this assay detects the number of cells in a wide range from 5×10 1 to 5×10 5 . The number of adherent cells was examined using the ATPlite kit (Perkin-Elmer), according to the manufacturer's recommendations, in a FluoStar plate-reader (BMG). Cells were seeded in white Packard Viewplates-96 (2500 cells/well) overnight in DMEM containing 10% FBS, followed by I3C treatment in the same medium for 48 h.
The following adjustments were made for 3D cultures. To measure ATP levels in cells grown in collagen gels, time periods for cell extraction and ATP assay were extended from 15 min to 90 min to obtain the highest measurements. Formed spheroids were treated with I3C for 48 h and transferred to Packard Viewplate-96 plates in aliquots/well, equivalent to 2.5×10 3 cells of the starting spheroid culture, for measuring ATP amounts as described above. In some experiments cells were treated with a highly specific EGFR inhibitor PD153035 (Calbiochem, UK) or EGF (Sigma).
Apoptosis was measured using the Annexin V-FITC kit (Bender Medsystems) as described previously. 13 The percentage of live, apoptotic or necrotic cells in the whole population was determined using a FACScan flow cytometer. In some experiments cycloheximide (Sigma), Z-YVAD-FMK (Sigma) or Z-VAD-FMK (Promega) was added to the cell culture medium 60 min prior to I3C. The effect of I3C on mitochondrial potential was measured via tetramethylrhodamine ethyl ester (TMRE) binding to I3C-treated adherent cells using a FACScan flow cytometer as described previously. 37 TMRE is a cationic lipophilic dye that accumulates in the negatively charged mitochondrial matrix.
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Caspase activity
Caspase-8 and -9 proteolytic activities were measured using colorimetric protease assays (Biosource) with specific substrates IETD-pNA and LEHD-pNA, respectively. Protein lysates (100 µg) of adherent MDA-MB-468 cells were processed according to the manufacturer's instructions. Absorbance of free chromophore pNA was quantified at 405 nm in the Fluostar plate-reader. Data are presented as a percentage of activity of non-induced controls after subtraction of negative controls without the specific substrate.
Caspase-3/7 activity was measured using Caspase-Glo 3/7 kit (Promega) according to the manufacturer's instructions. Cells were seeded in white Packard Viewplates-96 (10000 cell/well) overnight in 10% FBS in DMEM, followed by treatments in the same medium. Luminescence was detected in the Fluostar plate-reader 40 min after addition of luminogenic substrate containing Z-DEVD sequence specific for caspases-3 and/or -7. Data are presented as fold increase in luminescence of treated samples.
Protein analysis
Preparation of cell lysates, SDS-PAGE and immunoblotting were performed according to standard procedures. 38 Briefly, cells were extracted with a triple detergent buffer, containing inhibitors for proteases and phosphotyrosine and phosphoserine/phosphothreonine phosphatases (all cocktails from Sigma). Protein concentrations were measured using the Bio-Rad protein assay. Proteins were separated by SDS-PAGE, blotted onto nitrocellulose filters, incubated with primary antibodies followed by the secondary antibody conjugated to HRP (Dako) and detected with ECL or ECLplus (EGFR in HBl100 and MCF7 cells) reagent (Amersham). Western blots were routinely probed with several primary antibodies. Antibodies used in this study were against: EGFR (monoclonal R19/48, polyclonal pY845 and pY1068 from Biosource), Erk (monoclonal sc-7383 pErk and polyclonal sc-94 Erk-1 from Santa Cruz Biotechnology), Akt (polyclonal pS473 from Biosource; Akt-1 C-20 from Santa Cruz Biotechnology), β-actin (polyclonal from Sigma), N-cadherin (monoclonal 32; BD transduction laboratories), E-cadherin (monoclonal AF748; R&D Systems), β1-integrin (polyclonal sc-8978 from Santa Cruz Biotechnology). Protein bands on exposed films were quantified using a Syngene image system.
Data analysis
Differences among the groups were analyzed using one-way ANOVA in Statistical Package for the Social Sciences, followed by Scheffe's test to determine whether the treatment groups were different, or by Dunnett's test to determine whether the treatment groups were different from a control group. P < 0.05 was selected as the level of statistical significance.
Results
I3C-induced apoptosis
I3C caused apoptosis in MDA-MB-468 and MDA-MB-231 cells and necrosis in MCF7 cells after 24 h treatment with 256 µM I3C (Figure 1 ), which is close to a physiologically achievable range, identified recently by Anderton et al, who detected I3C ranging from 40 to 170 µM in several mouse tissues after a single dose administration. 39 After 48 h, I3C further increased cell death in MCF7, MDA-MB-468 and MDA-MB-231 cells ( Figure 1 ). Increased necrosis in MDA-MB-468 and MDA-MB-231 cells after 48 h treatments is likely to be secondary to apoptosis and a consequence of further disintegration of apoptotic cells. Cell death in the presence of 256 µM I3C in this assay was in the order MDA-MB-231 < MCF7 < MDA-MB-468. In contrast to cancer cells, transformed HBL100 cells underwent necrosis only at a non-physiological concentration of 512 µM.
Significantly increased activity of effector caspases 3/7 was found after 30 h of I3C treatments in MDA-MB468 and MDA-MB-231, but not HBL100 or MCF7 cells ( Figure 2A ). The levels of the effector caspase activity correlated with the levels of apoptosis, detected by annexin V binding, observed in these cells ( Figure 1 ). MCF7 cells possess a non-functional caspase-3 gene. 40 In agreement with this, no increase in caspase 3/7 activity nor phosphatidylserine externalisation was observed in MCF7 cells despite significant I3C-induced loss of viability. I3C-induced activation of effector caspases did not require protein synthesis ( Figure 2B ). In fact, inhibition of protein synthesis during I3C treatment enhanced activation of caspases in MDA-MB-468 cells and induced activation in HBL100 cells, which did not develop apoptosis after the treatment with I3C alone.
The apoptotic process in the most susceptible cells, MDA-MB-468, was investigated in detail. I3C-induced apoptosis was significantly reduced by a pan-caspase inhibitor Z-VAD-FMK, but not by a caspase-1-specific inhibitor Z-YVAD-FMK ( Figure 3 ). The mRNA level of caspase-1 was not changed in the presence of I3C (not shown). Treatment with 125 µM I3C induced loss of mitochondrial membrane potential after 20 h treatment ( Figure 4A ). Two-fold activation of an initiator caspase-9 was observed after 20 h treatment followed by weak activation of caspase-8 after 24 h ( Figure 4B ). Activity of effector caspases 3/7 was increased by 2 fold after 24 h of treatment with 125 µM I3C ( Figure 4C ). Apoptosis, measured using phosphatidylserine externalisation dependent on caspase-3 activity, 41 was detected starting from 24 h of treatment ( Figure 4D ). Taken altogether, these data implied that I3C induced caspase-dependent apoptosis, initiated by the loss of mitochondrial membrane potential and activation of the initiator caspase-9, followed by Figure 1 . I3C induced necrosis in HBL100 and MCF7 cells and apoptosis in MDA-MB-468 and MDA-MB-231 cells. The percentage of live, apoptotic and necrotic cells in the populations was measured after 24 h and 48 h of treatment with I3C (µM). All data are presented as percentage of means ± SD. * , P < 0.05 (n = 4) compared to "no I3C". activation of effector caspases 3/7 and phosphatidylserine externalisation. This sequence of events is indicative of the mitochondrial apoptotic pathway. Since MCF7 cells do not display typical features of apoptosis, we investigated whether I3C affected mitochondrial membrane potential in these cells. I3C induced significant loss of mitochondrial membrane potential in a time-dependent manner ( Figure 5A ) similar to MDA-MB-468 cells. The rate of loss of membrane potential exceeded the rate of decreasing viability in these cells ( Figure 5B ). Therefore, we concluded that I3C-induced cell death in all cancer cells proceeded via the mitochondrial apoptotic pathway, although the absence of functional caspase-3 in the MCF7 cells prevented the final apoptotic outcome.
Effect of the 3D environment on susceptibility of breast cancer cells to I3C
Viability of cells grown as monolayers on plastic was reduced by I3C in the concentration range of 128-256 µM (Table 1 ) with susceptibility to 256 µM I3C in the same order (HBL100 < MDA-MB-231 < MCF7 < MDA-MB-468), as determined by measuring apoptosis. The MDA-MB-231 and MCF7 cells were slightly more resistant to 512 µM I3C compared to HBL100 cells. MDA-MB-468 cells were two-four times more susceptible to I3C compared to other cell types.
Collagen gel culture significantly increased the viability of transformed HBL100 cells in the presence of I3C (Table 1) , conferring resistance to 256 µM in a 3D environment. On the contrary, the cancer cells MCF7 and MDA-MB-468 in collagen culture exhibited lower viability in the presence of 32-256 µM I3C compared to that on plastic. Addition of basement membrane (matrigel) proteins to collagen I gels did not affect I3C susceptibility of MDA-MB-468 cells compared to that of collagen I gel (not shown). I3C inhibited MDA-MB-468 cell growth in both types of gel to a greater extent than in monolayer culture. Interestingly, MCF7 cells were more resistant to 512 µM I3C compared to HBL100 cells in collagen gel culture. The susceptibility of the aggressive metastatic cell line MDA-MB-231 was not affected by Figure 2 . I3C induced activation of caspase 3/7 activity in MDA-MB-468 and MDA-MB-231 cells, but not in HBL100 or MCF7 cells. (A). Caspase3/7 activity was measured in cells treated with 125, 250 and 500 µM I3C for 30 h. * , P < 0.05 (n = 6) compared to "no I3C". (B.) I3C-induced apoptosis was increased by inhibition of protein synthesis in MDA-MB-468 and HBl100 cells. Caspase3/7 activity was measured in cells treated with 10 µM of cycloheximide (CX) for 1 h, followed by 250 (MDA-MB-468) or 500 (HBL100 and MDA-MB-231) µM I3C for another 30 h. * , P < 0.05 (n = 6) compared to "no I3C". #, P < 0.05 compared to "I3C alone". culturing in collagen gel. The susceptibility of breast cells grown in collagen gel in the presence of 256 µM I3C was in the order MDA-MB-231 < MCF7 < MDA-MB-468.
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Viability of transformed HBL100 cells grown as spheroids in the presence of 128-512 µM I3C was dramatically increased compared to that of a monolayer. A small increase in viability of MCF7 cells in spheroids was observed only in the presence of 512 µM I3C. MDA-MB-468 spheroids were more susceptible to the presence of 128-256 µM than cells grown on plastic. The sensitivity of the metastatic MDA-MB-231 cells was not affected by 128-512 µM I3C when cultured as spheroids, but was increased in response to 32-64 µM I3C. The susceptibility in spheroid cultures to 256 µM I3C was in the same order as that in collagen gel culture.
Altogether these results indicated that 3D culturing conditions could affect susceptibility of cells to I3C, when compared with monolayers, decreasing viability of MCF7 and MDA-MB-468 cells in the presence of 32-256 µM I3C.
In contrast, viability of the transformed HBL100 cells in the presence of I3C in both 3D cultures was significantly increased compared with that in a monolayer on plastic. In fact, HBL100 cells were resistant to 128-256 µM I3C in 3D culturing conditions, whereas all cancer cells were susceptible to these concentrations. MDA-MB-468 cells in all culturing conditions were significantly more susceptible to 128-256 µM of I3C compared to other cell lines. The sensitivity of the aggressively metastatic cell line MDA-MB-231 was mostly unaffected by 3D culturing conditions, although a small increase in susceptibility to low I3C concentrations was observed in spheroids.
The effect of I3C on normal human fibroblasts was also investigated. I3C did not induce activity of caspase3/7 in fibroblasts ( Figure 6A ), but caused necrosis in a small proportion of fibroblasts ( Figure 6B ). Their viability in a monolayer was slightly decreased by 512 µM I3C ( Figure 6C ). Fibroblasts grown in collagen gel were more susceptible to 384-512 µM I3C compared to a monolayer culture ( Figure 6C ). However, the fibroblasts were much more resistant to I3C compared to tumorigenic cells (compare Figure 6 and Table 1 ). They did not form spheroids, as no live cells survived following overnight suspension. Collectively, these data indicated that the fibroblasts were significantly less susceptible to I3C compared to tumorigenic cells.
EGFR is involved in I3C induced cell death
The mitochondrial apoptotic pathway is inhibited by growth factors. EGFR is overexpressed in MDA-MB-231 and MDA-MB-468 cells, 42, 43 which undergo apoptosis in response to EGF. 44 For these reasons we investigated whether I3C might affect EGFR signaling. I3C treatment of MDA-MB-468 cells resulted in increased phosphorylation (163%) of the activation loop of EGFR (Y845) after 6 h, increased autophosphorylation (Y1068, 128-123%) and reduced EGFR expression (82-71%) after 6-12 h of I3C treatment ( Figure 7A and C). I3C-induced EGFR activation resulted in increased Erk signalling (181-172%) at 6-12 h. EGFR levels were restored after 18-30 h of I3C treatment in MDA-MB-468 cells ( Figure 7D) ; however, the apoptotic program was already switched on at that time ( Figure  4) . No changes in EGFR levels were detected in other cells during 6-12 h of I3C treatment ( Figure 7B ), but reductions in EGFR expression were detected after 24-30 h in MDA-MB-231 and HBL100 cells ( Figure 7D and E) . Since I3C-induced EGFR downregulation was detected in three out of four tested tumorigenic cell lines, we investigated whether downregulation of EGFR function was responsible for cell death using a specific EGFR tyrosine kinase inhibitor PD153035. The inhibitor induced activation of caspase-3/7 activity in MDA-MB-468, MDA-MB-231 (5-20 µM) and HBL100 (10-20 µM) cells and reduced it in human fibroblasts (5-20 µM) ( Figure 8A ). EGFR inhibitor PD153035 reduced viability of MDA-MB-468 (5-20 µM), MDA-MB-231, MCF7 and human fibroblasts (10-20 µM), but not HBL100 cells ( Figure 8B ). MDA-MB-468 and MDA-MB-231 cells were particularly sensitive to inhibition of EGFR signaling; therefore, I3C-induced downregulation of EGFR in these cells, but not in HBL100 cells, is likely to be responsible for caspase activation and apoptosis.
There is a body of evidence on the role of EGFR in cell adhesion (see Discussion section); hence, we investigated whether EGFR modulated I3C-induced cell death in MDA-MB-468 cells in 3D conditions. EGFR was either stimulated by EGF or inhibited by 100 nM PD153035, which did not affect cell viability. EGF stimulation, but not the EGFR inhibitor, reduced cell viability and further increased cell death in the presence of I3C in monolayer culture ( Figure 9A ). In collagen culture, both EGF and EGFR inhibitor significantly reduced cell viability and I3C did not increase cell death in the presence of EGF or EGFR inhibitor probably due to a low viability level in the presence of I3C in collagen ( Figure 9B ). EGF significantly increased cell number in spheroid culture in contrast to that in monolayer or collagen, however, the EGFR inhibitor reduced cell viability in spheroids similarly to that in collagen ( Figure 9C ). I3C still reduced viability, while EGF increased cell proliferation in spheroids in the presence of I3C. The combination of the EGFR inhibitor with I3C almost completely eliminated cells. Protein analysis demonstrated that expressions of EGFR, β1 integrin and actin were affected by 3D conditions ( Figure 9D and E). Actin expression was increased in 3D conditions. EGFR was present in two forms 170 and 140 kDa in monolayer and collagen cultures, but only as 170 kDa in spheroids. Collagen culture significantly decreased EGFR levels. β1 Integrin was expressed as several isoforms with different dominant isoforms in each type of culture. These experiments further support EGFR involvement in the viability of cancer in a 3D environment and the I3C-induced response.
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Discussion
Comparison of breast tumorigenic cells with normal fibroblasts showed that normal tissue-derived cells are much more resistant to I3C compared to tumorigenic cells. Similarly normal cells have shown greater resistance to other dietary phytochemicals, such as EGCG and curcumin. 45, 46 Cell viability in the presence of 256 µM I3C was in the order fibroblasts = HBL100>MDA-MB-231>MCF7>MDA-MB-468. Our data indicate that I3C induced cell death in breast cancer cells at concentrations close to the physiologically achievable range. I3C-induced cell death was initiated by the loss of mitochondrial membrane potential, followed by development of the apoptotic program, which was unable to proceed in the normal way in MCF7 cells due to the lack of functional caspase-3. I3C-induced cell death in cancer cells should be distinguished from necrosis in transformed HBL100 cells and normal fibroblasts, caused by cytotoxicity of non-physiological high I3C concentrations. Our data, which are in agreement with the levels of I3C-induced apoptosis in MDA-MB-468, HBL100 and MCF7 cells, 12, 13 now provide a mechanism involving signaling from EGFR via a mitochondrial pathway.
Since I3C has been reported to upregulate expression of pro-apoptotic proteins, e.g. DR4, DR5, caspase-1 and Bax, at transcriptional and protein levels in various cell types, [14] [15] [16] 19 we investigated if I3C-induced apoptosis requires protein synthesis. Inhibition of protein synthesis with cycloheximide did not reduce I3C-induced apoptosis. On the contrary, inhibition of protein synthesis increased apoptosis in MDA-MB-468 cells and induced apoptosis in HBL100 cells. In fact, protein synthesis protected HBL100 cell from I3C-induced apoptosis. Because of contradictory reports on the mechanism of I3C-induced apoptosis in different cell types and potential involvement of the initiator caspase-1, we investigated which initiator caspases and apoptotic pathways were involved in MDA-MB-468 cells. Although I3C-induced apoptosis was significantly reduced by a pan-caspase inhibitor ZVAD-FMK, a caspase-1-specific inhibitor did not have any effect. Loss of mitochondrial membrane potential and activation of initiator caspase-9 were the earliest detected apoptotic events followed by activation of effector caspases-3/7 and increased phosphatidylserine externalization. Similarly, I3C induced significant loss of mitochondrial membrane potential prior to the loss of cell viability in MCF7 cells. 
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in HBL100 and MCF7 cells was performed using different ECL substrate and exposure times compared with those in other cell lines. Quantified results of 3 experiments (A and D) are shown on graphs (C and E, respectively). * , P < 0.05 versus "no I3C".
The sequence of I3C-induced events involved a mitochondrial apoptotic pathway in cancer cells.
Further investigation indicated that 3D culturing conditions dramatically influenced I3C susceptibility of all non-metastatic cell lines in this study. The transformed HBL100 cells became resistant to 128-256 µM I3C in 3D conditions, whereas two cancer cell lines, MCF7 and MDA-MB-468, became more susceptible. Interestingly, a similar effect of laminin-based 3D culture on induced cell death has been reported. 24 In that study transformed mammary S-1 cells underwent apoptosis following exposure to several agents in a monolayer, but not in 3D culture. Conversely, tumorigenic T4-2 cells underwent apoptosis in both culturing conditions and were more susceptible to chemically induced apoptosis in 3D culture. β4 Integrin was responsible for modulation of apoptosis in that study. This integrin does not support adhesion to collagen and is not expressed in either MCF7 or MDA-MB-468 cells. 32 Our data indicated that β1 integrin was modulated by 3D conditions in MDA-MB-468 cells. Culturing MCF7 cells in collagen gels increased susceptibility to I3C compared to a monolayer, but spheroid formation did not. Nor did spheroids protect these cells from I3C in contrast to reports of protection against other agents. 26 It is noteworthy that MCF7 viability increased in 3D conditions at 512 µM I3C. This raises the possibility that a small proportion of cells would remain viable even at high concentrations of I3C in vivo, despite the majority of the population being I3C-sensitive. This implies that additional therapies may be required for certain cancer cell types to eliminate such cancer cells completely.
The susceptibility of the metastatic cancer cells MDA-MB-231 was mostly unaffected by culture conditions, although a slight reduction in cell viability of spheroids was detected in the presence of low I3C concentrations. Recent studies indicate that metastatic breast cancer cells express activated αvβ3 integrin, which prevents apoptosis when cell adhesion is impaired, e.g. in blood flow. 47 Therefore, cell viability of metastatic cancer cells may not be influenced by adhesion to the same extent as that of other cancer cells.
The mitochondrial apoptotic pathway is blocked by growth factor signaling in live cells. EGFR is markedly overexpressed in MDA-MB-468 and MDA-MB-231 cells, Figure 8 . Viability of breast cancer cells MDA-MB-468 and MDA-MB-231 was EGFR-dependent. Caspase 3/7 activity (A, n = 6) or viability (B, n = 16) were measured in cells treated with 0.5-20 µM of EGFR inhibitor PD153035 for 30 h. (A-B) The data are presented as the means ± SE. * , P < 0.05 versus "no inhibitor".
which undergo I3C-induced apoptosis. Reported levels of EGFR are much higher in MDA-MB-468 (2×10 6 /cell) and MDA-MB-231 cells (3-7×10 5 /cell) compared with HBL100 (0.8×10 4 /cell) or MCF7 (0.8×10 3 /cell). 42, 43 For these reasons, we investigated EGFR signaling in I3C-treated cells. In MDA-MB-468 cells, I3C induced EGFR activation and autophosphorylation, leading to EGFR degradation as a part of a negative feedback-loop. 21 EGFR activation resulted in increased downstream Erk signaling. EGFR is an important factor in maintaining cell survival. I3C-induced downregulation of EGFR occurred prior to initiation of the apoptotic program in MDA-MB-468 cells. Analysis of EGFR expression indicated that I3C reduced levels also in MDA-MB-231 and HBL100 cells, although the dynamics were different in these cells with downregulation of EGFR occurring much later than in MDA-MB-468 cells. These differences may account for super-sensitivity of MDA-MB-468 cells. Similarly, I3C-induced reduction of EGFR has been reported after 24 h in prostate cancer PC3 cells by Sarkar and co-authors. 17 However, I3C-induced apoptosis was attributed to reduction in Akt activation in that study. In contrast, no reduction in Akt activation was observed in our study in any cell line tested at concentrations which induced significant apoptosis, although reduction in pAkt in MDA-MB-468 cells was reported for higher I3C concentrations. 13 Figure 9 EGFR modulated viability of MDA-MB-468 cells in response to I3C in the 3D environment. Viability of cells grown on plastic (A, n = 16), in collagen I gels (B, n = 16) or spheroids (C, n = 8) was determined after 48 h treatment with 125 µM I3C in the presence or absence of 100 ng/ml EGF or 100 nM PD153035. (A-C) The data are presented as the means ± SE. * , P < 0.05 versus "no treatment". # ,P < 0.05 versus cells with the same EGFR modulation in the absence of measured in cells treated with 13C.ˆ, P < 0.05 versus "I3C only". D. Two independent cultures, grown as in controls in A-C, were analyzed using western blotting (40 µg of protein extract/lane), developed with the antibodies indicated on the right. Molecular weight markers are shown on the left. E. Quantified results of experiment D. * , P < 0.05 versus monolayer.
Since inhibition of EGFR signalling with the specific inhibitor PD153035 resulted in activation of effector caspases and significant loss of viability in MDA-MB-468 and MDA-MB-231 cells, I3C-induced reduction of EGFR is likely to have a similar effect. Interestingly, the EGFR inhibitor induced 1.9-fold caspase activation in HBL100 cells, but no significant loss of viability was detected. These cells seem to be resistant to this level of caspase activation. Similarly, I3C-induced reduction in the EGFR did not result in cell death in these cells. Since blocking synthesis of new proteins in I3C-treated HBL100 cells induced apoptosis, it is possible that sustained downregulation of EGFR is required to induce apoptosis in these cells. The MCF7 cells exhibited some level of sensitivity to EGFR inhibition, but the effect of I3C on EGFR could not be reliably detected in these cells due to extremely low EGFR expression. Hence, involvement of EGFR could not be ruled out completely, particularly because of cross-talk between ER and EGFR pathways in MCF7 cells. 48 Inhibition of EGFR in human fibroblasts resulted in reduced cell numbers without caspase activation, which may contribute to some of the common side effects observed in patients treated with EGFR inhibitors, such as skin rashes.
Modulation of cell viability in collagen gels or spheroids might be related to adhesion receptors, α2β1 integrin and cadherins involved in cell-extracellular matrix (collagen I) interactions or cell-cell interactions, respectively, and would impact differently on the physiology of different cancer cell types. However, no changes in N-cadherin (HBL100 cells), E-cadherin (MCF7 and MDA-MB-468 cells) or cadherin-11 (MDA-MB-231 cells) were observed after I3C treatment or in 3D conditions (MDA-MB-468). On the other hand, a large body of evidence implicates EGFR in cell adhesion, particularly in the 3D environment. EGFR affects cell-extracellular matrix adhesion in breast cancer cells, co-precipitates with cell adhesion receptors integrins and is activated by β1 and αvβ3 integrins. 49, 50 Integrin-dependent adhesion in monolayer culture increases EGFR on the cell surface. 49 EGF stimulation resulted in decreased and increased adhesion of MDA-MB-468 and MDA-MD-231 cells, respectively. 51 EGFR regulates assembly of E-cadherin-actin adhesion complexes in MDA-MB-468 cells. 52 Moreover, EGFR is implicated in protection from apoptosis in bladder cancer spheroids. 53 In contrast to integrin-based adhesion, EGFR expression is downregulated in A431 spheroids. 49, 54 Interestingly, EGF stimulation induces apoptosis in monolayer culture in several cancer cell lines, including MDA-MB-468 cells. 44 In MDA-MB-468 cells, expression of several proteins was modulated by 3D conditions. Decreased EGFR expression in collagen gel may account for increased sensitivity to EGF or the EGFR inhibitor, compared to those in monolayer culture. EGFR was expressed as 170 and 140 kDa bands in monolayer and collagen cultures. The latter is likely to represent a constitutively active EGFRvIII isoform, which may originate from alternative splicing of the ligand-binding site in the extracellular domain, found in several cancer types including breast cancer. 20, 21, 42 The absence of this particular isoform in spheroids may account for normal response to EGF, e.g. increasing cell numbers. EGF increased viability of MDA-MB-468 spheroids in the presence of I3C; similarly, EGF-induced protection from apoptosis has been reported for bladder cancer spheroids. 53 In contrast to opposite effects of EGF stimulation in the different 3D cultures, the EGFR inhibitor caused a loss of cell viability in both collagen gels and spheroids. Since EGFR is involved in assembly of both integrin and cadherin complexes, EGFR inhibition may negatively affect formation of cell adhesion complexes in both types of 3D culture and, thereby, decrease cell viability. Therefore, EGFR modulation using either a specific inhibitor or EGF stimulation had a significant effect on the behavior of MDA-MB-468 cells in 3D culture and in the presence of I3C.
Collectively, our data indicated that changes in EGFR expression preceded any other events induced by I3C in MDA-MB-468 cells or coincided with the onset of apoptosis in MDA-MB-231 cells, implicating this receptor in I3C-induced apoptosis in EGFR-dependent breast cancer cells. EGFR-dependence of some lung and colon cancers has been confirmed in recent and ongoing trials with small EGFR tyrosine kinase inhibitors. 20 We have not identified factors involved in I3C-induced death of MCF7 cells; therefore, EGFR cannot be considered as the only biomarker implicated in I3C-induced cancer cell death.
Conclusions
The current study has provided an initial characterization of breast cancer cell types and conditions rendering cells susceptible to I3C. In 3D conditions, I3C, in a physiological range of concentrations, induced cell death and loss of viability only in cancer cells, regardless of their ER status or p53 function, in contrast to its lack of effect in transformed or normal cells. 3D culture abrogated any susceptibility of the transformed cell line HBL100 and increased resistance of MCF7 cells to high concentrations of I3C. These data imply that some cell types are resistant to I3C or cannot be eliminated completely by treatment with I3C alone, particularly in a 3D environment in vivo. Our data show an important role of EGFR in susceptibility to I3C, modulated by cell adhesion in cancer cells. We speculate that malignant EGFR-dependent and some other cancer phenotypes are likely to be susceptible to I3C in vivo. Further analysis of prognostic biomarkers and signaling pathways in I3C-sensitive cancer types will provide critical information for identifying cancer types susceptible to I3C and for developing I3C-supplemented anti-cancer therapies or prevention strategies. Use of I3C in combination with other anti-EGFR therapies should be explored in order to gain maximal benefits from anti-EGFR therapy.
